Abstract: The invention relates to a methods and systems for determining an insulin dosing recommendation. The invention employs Linear Quadratic methodology to determine the insulin dosing recommendation based on a patient's present physiological state, which is estimated by an adaptive filter methodology employing a dynamic model, which utilizes real-time measurements of blood glucose concentration.

Abstract: An adjustable and self-locking fixation device for fixedly securing two structures wherein the device comprises two spans and a receiving aperture configured to receive the spans and form a closed loop around a first structure. The two spans are further configured to secure and lock onto each other so as to form a second closed loop around the two structures and secure the two structures in a tensioned state.

Abstract: An aspect of an embodiment or partial embodiment of the present invention (or combinations of various embodiments in whole or in part of the present invention) comprises, but not limited thereto, a method and system (and related computer program product) for continually assessing the risk of hypoglycemia for a patient and then determining what action to take based on that risk assessment. A further embodiment results in two outputs: (1) an attenuation factor to be applied to the insulin rate command sent to the pump (either via conventional therapy or via open or closed loop control) and/or (2) a red/yellow/green light hypoglycemia alarm providing to the patient an indication of the risk of hypoglycemia. The two outputs of the CPHS can be used in combination or individually.

Abstract: Embodiments disclose a system for determining a sensitivity of a networked system. The system identifies a vertex (V) that represents a constituent and a state of the constituent, and an interaction (E) between at least two Vs. An interaction-dependent function provides a probability that, when a perturbation occurs, a V will be in a certain state given that it is currently in a determined state and its neighbors are currently in determined states. A network reliability is used to determine a probability that a V's state holds when a perturbation occurs. The system evaluates only a certain amount of terms in a Taylor series from a sample, and identifies interpolating polynomials between the Taylor series. A cost function optimizes a property of the networked system for a fixed cost. The system perturbs the networked system until reliability is zero to estimate a sensitivity of the networked system.

Abstract: The present application discloses a previously unknown function of CD24 expressed on a subset of dendritic cells. The invention encompasses regulating CD24 on these cells to regulate erythropoiesis, induce EPO production and levels, increase RBC levels, and to treat, for example, stress-mediated erythropoiesis. The compositions and methods of the invention are useful, for example, in treating anemia.

Abstract: Compositions and methods are provided that are useful for diagnosing, treating, and monitoring alcohol dependence and disorders, susceptibility to alcohol dependence disorders, as well as drug related dependence and disorders. The methods include treating patients with an antagonist of the serotonin receptor 5-HT3 for such disorders, wherein the patient's serotonin transporter gene SLC6A4 is known to have particular genotypes.

Abstract: System and method directed towards providing full and even illumination of a patient's retina through lighting integrated into a handheld fundus lens. By integrating the lighting, the method and system reduces and even eliminate many lens artifacts and reflections. By increasing the accuracy, quality, and field of view afforded during clinical examination of the retina, the method and system will allow practitioners to make more accurate diagnoses and will increase safety during retinal surgical procedures.

Abstract: Relapsing remitting multiple sclerosis (RRMS) is the most common form of multiple sclerosis, affecting more than 80% of MS patients. RRMS is comprised of two phases: the auto-inflammatory episodes, in which the immune system is actively destroying myelin, alternate with remission phases. Currently there is no cure for this devastating disease. The present disclosure provides compositions and methods useful for inducing remyelination. The methods are useful for promoting remyelination to treat diseases and disorders such as MS. The present disclosure describes compositions and methods useful for inhibiting LRP1 activity. In one aspect, a siRNA against LRP1 can be used. It is disclosed that myelination can be regulated by inhibiting the interaction of LRP1 and p75NTR and that it inhibits activation of Rho-A.

Abstract: A method of synthesis of metal organic frameworks (“MOFs”) includes preparing a metal solution by dissolving at least one metal salt in an aqueous solution and buffering the metal solution with a base to achieve a first pH, the metal solution optionally comprising an organic co-solvent, preparing a linker solution by adding at least one organic acid linker and at least one base to an aqueous solution, and mixing the metal solution and the linker solution to produce the MOFs. The at least one organic acid linker has an ability to be protonated or deprotonated in response to a second pH, and the mixture of the metal solution and the linker solution has a third pH value, where the third pH value is greater than a highest pKa of the organic acid linker. The MOFs may be applied to a textile.

Abstract: The present disclosure provides anti-SAS1B antibodies, antigen-binding fragments thereof, and antibody-drug conjugates and methods of their use. This present disclosure also provides an isolated antibody or antigen-binding portion thereof having at least one of SB antibodies binding to surface exposed SAS1B, and 6B1 antibodies identifying at least one set of cancer patients testing positive for SAS1B expression.

Abstract: The present application discloses a novel fusion peptide of IL-2 and IL-33 and its use. It comprises a biologically active domain of Interleukin-2 (IL-2) or a biologically active fragment or homolog thereof, and a biologically active domain of Interleukin-33 (IL-33) or a biologically active fragment or homolog thereof. The two portions can be linked by a linker sequence. The application discloses that combination therapies using IL-2 and IL-33 or a therapy using the IL233 fusion protein are effective in preventing or treating diseases and disorders such as autoimmune diseases and disorders, inflammation, etc. Depending on the subject's disease or disorder, the compositions of the invention are useful for preventing certain symptoms, treating the disease, and alleviating at least some of the symptoms.

Abstract: Methods, systems, and computer readable media for defining risk of adverse health outcomes based on non-intrusive energy usage monitoring are disclosed. One exemplary method includes receiving residential energy usage data associated with a residential location as measured by a residential meter and applying at least one load signature correlation that has been derived using previously collected energy usage data and one or more of health outcome data, the health care resource utilization data, and the clinical outcome data to the received residential energy usage data. The method further includes using an output resulting from applying the at least one load signature correlation to identify a risk or predict a likelihood of specific health outcomes or clinical events associated with at least one target entity associated with the residential location.

Abstract: The disclosure provides methods for treating a subject suffering from a disease associated with sodium channel activity. The method comprises administering to the subject a therapeutically effective amount of a compound according to Formula II or Formula III described in the specification, or a pharmaceutically acceptable salt, prodrug, tautomer, stereoisomer, hydrate, or solvate thereof.

Abstract: A method and system for promoting the union of a bone fracture and/or fusion of bones across a joint space at a target region of a subject which may be accomplished by: inserting a surgical implant device at the target region; providing a guide member in the surgical implant device bore; sealing the surgical implant device bore distal opening and/or the surgical implant device bore proximal opening with the guide member; and positioning the guide member relative to the surgical implant device to provide for the guide member to be partially absent from the surgical implant device bore to allow the biomaterial and/or biologically active agents to extrude or diffuse from the activated apertures to the target region of the subject.

Abstract: In one aspect, in accordance with one embodiment, a method includes acquiring magnetic resonance (MR) data corresponding to bone tissue in an area of interest of a subject that is heated from the application of localized energy. The acquiring includes applying a three-dimensional (3D) ultra-short echo time (UTE) spiral acquisition sequence. The method also includes detecting, from the acquired magnetic resonance data, a change in MR response signal due to a change in at least one of relaxation rate and magnetization density caused by heating of the bone tissue; and determining, based at least in part on the change in the MR response signal, that the temperature of the bone tissue has changed.

Abstract: Systems and methods for epicardial electrophysiology and other procedures are provided in which conditions at the location of an access needle may be determined according to the detection of different pressure frequencies in separate organs, or different locations, in the body of a subject. Methods may include inserting a needle including a first sensor into a body of a subject, and receiving pressure frequency information from the first sensor. A second sensor may be used to provide cardiac waveform information of the subject, and the pressure frequency information may be segmented based on the cardiac waveform information. Conditions at the current location of the needle may be determined based on an algorithm including the segmented pressure frequency information and the cardiac waveform information.

Abstract: Methods and compositions for inhibiting a soluble B cell activating factor (BAFF) biological activity are disclosed, as are methods for treating aortic aneurysm (AAA) are also disclosed. Exemplary compositions include a reagent, such as an antibody, that interacts with a BAFF polypeptide or BAFF gene product and a carrier, whereby inhibition of BAFF multimerization substantially without depletion of mature B cells is accomplished.

Abstract: Some aspects of the present disclosure relate to systems and methods for magnetic resonance thermometry. In one embodiment, a preliminary balanced steady state free precession (bSSFP) magnetic resonance imaging pulse sequence is applied to an area of interest of a subject. Based on bSSFP image phases, a relationship between frequency and image phase associated with the area of interest can be determined and a bSSFP magnetic resonance imaging pulse sequence applied for temperature change measurement during and/or after focused energy is applied to the subject. Based on image phase change associated with temperature change and using the determined relationship between frequency and image phase, a change in the resonance frequency associated with the target area due to the application of the focused energy can be determined, and the temperature change can be determined based on the determined change in the resonance frequency.

Abstract: An air-inlet duct includes an outer wall, an inner wall, and a splitter. The splitter cooperates with the outer wall to establish a particle separator which separates particles entrained in an inlet flow moving through the air-inlet duct to provide a clean flow of air to a compressor section of a gas turbine engine.

Abstract: A probe chip device and a method for fabricating a probe chip device with an integrated diode sensor are disclosed. In one example, a probe chip device includes a beam head element that includes at least one probe tip that is configured to electrically probe a device under test. The probe chip device further includes a diode sensor that is heterogeneously integrated on the beam head element and is proximally positioned to the at least one probe tip.